Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025;25(12):1467-1491.
doi: 10.2174/0115680266325847241121034100.

A Comprehensive Review of mRNA-based Vaccines for COVID-19, A New Era in Pharmaceuticals: Unspecified and Unknown Aspects, Effects and Challenges

Pegah Vosoughi  1 , Seyed Morteza Naghib  1 , Mehdi Rahmanian  2 , M R Mozafari  3
Affiliations
Review

A Comprehensive Review of mRNA-based Vaccines for COVID-19, A New Era in Pharmaceuticals: Unspecified and Unknown Aspects, Effects and Challenges

Pegah Vosoughi et al. Curr Top Med Chem. 2025.

Abstract

Ongoing research and development efforts are currently focused on creating COVID-19 vaccines using a variety of platforms. Among these, mRNA technology stands out as a cuttingedge method for vaccine development. There is a growing public awareness of mRNA and its potential in vaccine development. Despite being relatively recent, extensive scientific research has been dedicated to vaccines for a considerable period. mRNA vaccines are created by synthesizing the spike protein from a DNA template. This review delves into the various aspects of these vaccines and thoroughly explores the intricacies of COVID-19 vaccinations. It is essential to choose a reliable, efficient, and widely accessible vaccine to combat COVID-19. However, due to the possibility of virus mutations, developing a dependable and safe vaccine is crucial to prepare for future outbreaks of SARS-CoV-2 variants. Meanwhile, concerns remain regarding the potential risks associated with these vaccines.

Keywords: COVID-19; DNA template; SARS-CoV-2.; Spike protein; Vaccination; mRNA.

PubMed Disclaimer

References

    1. Plotkin S.A.; Vaccines: The fourth century. Clin Vaccine Immunol 2009,16(12),1709-1719 - DOI - PubMed
    1. Gote V.; Bolla P.K.; Kommineni N.; Butreddy A.; Nukala P.K.; Palakurthi S.S.; Khan W.; A comprehensive review of mRNA vaccines. Int J Mol Sci 2023,24(3),2700 - DOI - PubMed
    1. Rzymski P.; Szuster-Ciesielska A.; Dzieciątkowski T.; Gwenzi W.; Fal A.; mRNA vaccines: The future of prevention of viral infections? J Med Virol 2023,95(2),e28572 - DOI - PubMed
    1. Pardi N.; Hogan M.J.; Porter F.W.; Weissman D.; mRNA vaccines - A new era in vaccinology. Nat Rev Drug Discov 2018,17(4),261-279 - DOI - PubMed
    1. Hogan M.J.; Pardi N.; mRNA vaccines in the COVID-19 pandemic and beyond. Annu Rev Med 2022,73(1),17-39 - DOI - PubMed

MeSH terms

LinkOut - more resources